Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04597047Completed
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
Covid19
PrincipalinvestigatorStart date: 2020-07-09
NCT04375982Completed
Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests
Embolism and ThrombosisInfectionInflammation
PrincipalinvestigatorStart date: 2020-04-20
NCT04288921Completed
Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites
Influenza, HumanRespiratory Syncytial Virus Infections
PrincipalinvestigatorStart date: 2020-02-06

Research Network

Collaboration Network

22 collaborators·65 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

William Simon

New Medical Healthcare

Similar
2 trials

Shared therapeutic areas:

Embolism and ThrombosisInfectionsInflammation+2 more

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 2 trials
Similarity Score58%

Anita Scribner

Diagnostic Clinic of Longview

Moderately Similar
1 trials

Shared therapeutic areas:

Embolism and ThrombosisInfectionsInflammation

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score34%

Judith Kirstein

Rancho Paseo Medical Group

Moderately Similar
1 trials

Shared therapeutic areas:

Embolism and ThrombosisInfectionsInflammation

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score34%

Robert Rosen

Ardmore Family Practice

Moderately Similar
2 trials

Shared therapeutic areas:

COVID-19Influenza, HumanRespiratory Syncytial Virus Infections

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score34%

Andre Gvozden

Gvozden Pediatrics

Moderately Similar
2 trials

Shared therapeutic areas:

COVID-19Influenza, HumanRespiratory Syncytial Virus Infections

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score34%

Paul Wisman

Pediatric Research of Charlottesville

Related
1 trials

Shared therapeutic areas:

Influenza, HumanRespiratory Syncytial Virus Infections

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score24%

Michael Bell

Accel-West Volusia Pediatrics

Related
1 trials

Shared therapeutic areas:

Influenza, HumanRespiratory Syncytial Virus Infections

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score24%

Jeffrey Stewart

Family Medical Associates

Related
1 trials

Shared therapeutic areas:

Influenza, HumanRespiratory Syncytial Virus Infections

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score24%

Aftab Naz

Madera Family Medical Group

Related
1 trials

Shared therapeutic areas:

Influenza, HumanRespiratory Syncytial Virus Infections

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score24%

Adam Kaplan

North Texas Family Practice

Related
1 trials

Shared therapeutic areas:

Influenza, HumanRespiratory Syncytial Virus Infections

Worked with same sponsors:

LumiraDx UK Limited
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04597047PrincipalInvestigator

Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test

Covid19
Completed
NCT04375982PrincipalInvestigator

Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests

Embolism and ThrombosisInfectionInflammation
Completed
NCT04288921PrincipalInvestigator

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Influenza, HumanRespiratory Syncytial Virus Infections
Completed

All 3 trials loaded